Desoxycorticosterone pivalate (DOCP) should be started at 1.1–1.5 mg/kg SC or IM, not the manufacturer-labeled 2.2 mg/kg, with electrolytes rechecked at 10–14 days and again at 25 days after each injection to guide dose titration. The 2023 AAHA Selected Endocrinopathies Guidelines explicitly endorse 1.1–1.5 mg/kg as appropriate starting doses in most cases, citing evidence that the label dose is excessive for the majority of dogs.AAHA Clinical G…

The case for lower starting doses is well-supported. Starting at 1.1 mg/kg q30d maintained mean serum sodium:potassium (Na:K) ratios ≥32 throughout a 90-day trial, with no dog developing electrolyte abnormalities requiring medical intervention.Journal of Vete… Starting at 1.5 mg/kg q30d controlled clinical signs and electrolytes in the majority of dogs, and no dog in that cohort ultimately required the 2.2 mg/kg label dose.Journal of Vete… Plasma renin activity (PRA) was overly suppressed on 80.8% of assessments in dogs receiving 2.2 mg/kg, compared to elevated PRA on only 20.5% of assessments in dogs receiving 1.1 mg/kg — indicating that the label dose produces biochemical overtreatment in most patients.Journal of Vete… PRA suppression in DOCP-treated dogs has been confirmed as a consistent finding, with only 18.2% of dogs in one cohort requiring the full 2.2 mg/kg dose.Journal of Vete…

Dose titration is guided by serum electrolytes at 10–14 days and 25 days post-injection. If hyperkalemia or hyponatremia persist, the dose is increased. If electrolytes are normal, the dose is gradually decreased with continued monitoring.AAHA Clinical G… The median maintenance dose after starting at 1.5 mg/kg was 1.1 mg/kg (range 0.7–1.8 mg/kg), with dose reductions required in the majority of dogs after 2–3 months.Journal of Vete… Doses as low as 0.35 mg/kg have maintained electrolyte control in individual dogs.Journal of Vete…

The dosing interval can be extended beyond 30 days in most dogs. The duration of action of DOCP in newly diagnosed dogs ranges from 32 to 94 days (median 62 days), and in previously treated dogs from 41 to 124 days (median 67 days).Journal of Vete… An individualized dosing interval — defined as the DOCP duration of action minus 7 days — ranged from 38 to 90 days (median 58 days) across all dogs completing the protocol, with a median annual drug cost reduction of approximately 57.5%.Journal of Vete… If the dose is already low and electrolytes are stable, extending the interval to 28–30 days is a reasonable first step before further dose reduction.AAHA Clinical G…

One important caveat for newly diagnosed dogs: Na:K ratios are lower after the first DOCP treatment than after subsequent treatments, suggesting an acclimation period occurs and ratios stabilize after the second injection.Journal of Vete… Dosage increases based solely on the first post-injection assessment should be avoided unless electrolyte disturbances are severe, as requirements are likely higher for the initial treatment than for maintenance.Journal of Vete…

Young dogs (≤3 years) require higher DOCP doses than older dogs, though none in the available cohort required the full 2.2 mg/kg label dose.Journal of Vete…

Urine electrolytes are not useful for monitoring DOCP adequacy. Urine electrolyte values in undertreated dogs overlap substantially with those in overtreated dogs, and no discriminatory cutpoints exist for any urine analyte.American Journa… In the absence of commercially available PRA assays, monitoring should rely on serum electrolyte concentrations alone.American Journa…

Point-of-care electrolyte analyzers introduce systematic bias in dogs with hypoadrenocorticism. Both the IDEXX Catalyst Dx and IDEXX VetStat tend to read higher than reference laboratory methods for most analytes, with poor agreement for sodium and chloride specifically.Journal of Smal… Dosing decisions based on point-of-care results should account for this discrepancy, particularly when values are near decision thresholds.

All DOCP-treated dogs require concurrent glucocorticoid supplementation. Prednisone or prednisolone at <0.1 mg/kg/day is sufficient for most clinically stable dogs, with a ceiling of 0.25 mg/kg/day for long-term management.AAHA Clinical G… The dose should be doubled or tripled before known stressful events and reduced if signs of iatrogenic hypercortisolism develop (polyuria/polydipsia, polyphagia, panting, muscle wasting, elevated ALP, or hair loss).AAHA Clinical G…

Would you like guidance on how to manage a dog whose electrolytes remain abnormal despite dose escalation, or on the approach to an Addisonian crisis before long-term DOCP is initiated?